Walleye Capital LLC Baxter International Inc Call Options Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $693,557 - $918,904	-21,100 Reduced 60.98%	13,500 $451,000
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $1.37 Million - $1.58 Million	-36,200 Reduced 51.13%	34,600 $1.48 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $95,130 - $116,850	-3,000 Reduced 4.07%	70,800 $2.74 Million
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $1.09 Million - $1.43 Million	29,100 Added 65.1%	73,800 $2.79 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $403,797 - $481,568	10,100 Added 29.19%	44,700 $2.04 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $1.3 Million - $1.81 Million	34,500 Added 34500.0%	34,600 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $4,970 - $5,771	100 New	100 $5,000
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $748,880 - $825,976	-9,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $675,648 - $758,172	9,200 New	9,200 $753,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.